Abstract:TFMN exhibits strong antioxidant capacity and scavenged excessive reactive oxygen species to enhance neuronal protection. Furthermore, perforin can be discharged by cytotoxic T‐lymphocytes, triggered the release of MPS within the TFMN through perforin‐formed pores. Simultaneously, this mechanism protected neurons from perforin‐induced toxicity. The MPS liberated at the targeted site achieves optimal drug accumulation, thereby enhancing therapeutic efficacy in EAE mice. Excessive infiltration of neutrophil and inflammatory cytokines accumulation as well as the inadequate delivery of drugs to the targeted site are key pathological cascades in multiple sclerosis (MS). Herein, inflammation‐targeting biomimetic nano‐decoys (TFMN) is developed that inhibit the infiltration of immune cells and effectively deliver glucocorticoids to lesions for enhanced MS treatment. Nano‐decoys encapsulated with the glucocorticoid methylprednisolone (MPS) are prepared by coating neutrophil membrane (NM) on nanoparticles formed by the self‐assembly of tannic acid and poloxamer188/pluronic68. Benefiting from the natural inflammation‐targeting ability of activated neutrophil membranes, TFMN can target the lesion site and prevent neutrophils infiltration by adsorbing and neutralizing elevated neutrophil‐related cytokines, subsequently modulating the inflammatory microenvironment in experimental autoimmune encephalomyelitis mice. TFMN exhibits a strong antioxidant capacity and scavenged excessive reactive oxygen species to enhance neuronal protection. Furthermore, at the inflammation site, perforin, discharged by cytotoxic T‐lymphocytes, triggered the controlled release of MPS within the TFMN through perforin‐formed pores in the NM. Simultaneously, this mechanism protected neurons from perforin‐induced toxicity. The MPS liberated at the targeted site achieves optimal drug accumulation, thereby enhancing therapeutic efficacy. In conclusion, the innovative system shows potential for integrating various therapeutic agents, offering a novel strategy for CNS disorders.

Methylprednisolone Modulates the Tfr/Tfh ratio in EAE-Induced Neuroinflammation through the PI3K/AKT/FoxO1 and PI3K/AKT/mTOR Signalling Pathways

Genetic ablation of steroid receptor coactivator-3 promotes PPAR-β-mediated alternative activation of microglia in experimental autoimmune encephalomyelitis

Methylprednisolone alleviates multiple sclerosis by expanding myeloid-derived suppressor cells via glucocorticoid receptor and S100A8/9 up-regulation

Combined Treatment with Minocycline and Prednisone Attenuates Experimental Autoimmune Encephalomyelitis in C57 BL/6 Mice.

Mycophenolate Mofetil Improves Neurological Function and Alters Blood T-lymphocyte Subsets in Rats with Experimental Autoimmune Encephalomyelitis.

Methylprednisolone Regulates the Cytokine Production of PBMC from Multiple Sclerosis Patients

Knockdown of IFIT3 ameliorates multiple sclerosis via selectively regulating M1 polarization of microglia in an experimental autoimmune encephalomyelitis model

Methylprednisolone alleviates cognitive functions through the regulation of neuroinflammation in Alzheimer's disease

Inflammation‐Targeted Biomimetic Nano‐Decoys via Inhibiting the Infiltration of Immune Cells and Effectively Delivering Glucocorticoids for Enhanced Multiple Sclerosis Treatment

Pleiotrophin Regulates Functional Heterogeneity of Microglia Cells in EAE Animal Models of Multiple Sclerosis by Activating CCr-7/CD206 Molecules and Functional Cytokines.

Prmt5 Deficiency Inhibits CD4+ T-cell Klf2/S1pr1 Expression and Ameliorates EAE Disease.

Combination of methylprednisolone and minocycline synergistically improves experimental autoimmune encephalomyelitis in C57 BL/6 mice.

Modulation of the HMGB1/TLR4/NF-κB signaling pathway in the CNS by matrine in experimental autoimmune encephalomyelitis

Methyl Butyrate Alleviates Experimental Autoimmune Encephalomyelitis and Regulates the Balance of Effector T Cells and Regulatory T Cells

Upregulation Of Immunomodulatory Molecules By Matrine Treatment In Experimental Autoimmune Encephalomyelitis

Protective Effects of Matrine on Experimental Autoimmune Encephalomyelitis Via Regulation of ProNGF and NGF Signaling

IFN-β Regulates Th17 Differentiation Partly Through the Inhibition of Osteopontin in Experimental Autoimmune Encephalomyelitis.

Protecting effect of emodin in experimental autoimmune encephalomyelitis mice by inhibiting microglia activation and inflammation via Myd88/PI3K/Akt/NF-κB signalling pathway

JAK inhibition ameliorated experimental autoimmune encephalomyelitis by blocking GM-CSF-driven inflammatory signature of monocytes

Glutathione PEGylated liposomal methylprednisolone (2B3-201) attenuates CNS inflammation and degeneration in murine myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis

TPN10475 Constrains Effector T Lymphocytes Activation and Attenuates Experimental Autoimmune Encephalomyelitis Pathogenesis by Facilitating TGF-β Signal Transduction